NFE2L2 and metabolic dysfunction-associated steatohepatitis: This outcome, along with worsened NASH, displayed by HFFr-fed Nrf2-/- mice, suggests Nrf2 plays a previously unrecognized role in protection against fructose-driven metabolic disorder.